US Stock MarketDetailed Quotes
PCSA Processa Pharmaceuticals
- 0.8500
- -0.0928-9.84%
Close Dec 20 16:00 ET
- 0.8400
- -0.0100-1.18%
Pre 06:11 ET
2.78MMarket Cap-0.18P/E (TTM)
0.9855High0.8442Low195.00KVolume0.9250Open0.9428Pre Close171.10KTurnover6.73%Turnover RatioLossP/E (Static)3.27MShares7.400052wk High0.75P/B2.46MFloat Cap0.844252wk Low--Dividend TTM2.90MShs Float284.7980Historical High--Div YieldTTM14.98%Amplitude0.8440Historical Low0.8770Avg Price1Lot Size
About Processa Pharmaceuticals Company
Processa Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of drug products for the treatment of serious medical conditions. Its main product candidate is PCS499, which is intended for the treatment of Necrobiosis Lipoidica. The company was founded by David Young, Patrick Lin, Sian E. Bigora, Wendy Guy, and Chang Rung Chen on March 29, 2011 and is headquartered in Hanover, MD.
Company Profile
SymbolPCSA
Company NameProcessa Pharmaceuticals
Listing DateOct 2, 2020
Issue Price4.00
Founded2011
CEOMr. George K. Ng
MarketNASDAQ
Employees13
Fiscal Year Ends12-31
Address7380 Coca Cola Drive,Suite 106
CityHanover
ProvinceMaryland
CountryUnited States of America
Zip Code21076
Phone1-443-776-3133
Company Executives
- Name
- Position
- Salary
- George K. Ng
- Chief Executive Officer and Director
- 472.85K
- Dr. Sian E. Bigora, Pharm.D.
- Chief Development Officer
- 321.73K
- Russell L. Skibsted, M.B.A.
- Chief Financial Officer
- --
- Wendy Guy
- Chief Administrative Officer
- --
- Patrick Lin
- Chief Business and Strategy Officer
- --
- Justin W. Yorke
- Chairman of the Board
- 54.00K
- Dr. David Young, PhD,Pharm.D.
- Director and President, Research and Development
- 186.64K
- Khoso Baluch
- Independent Director
- 83.00K
- James R. Neal, M.B.A.,M.S.
- Independent Director
- 83.00K
- Geraldine Pannu
- Independent Director
- 54.00K
Heat List
US
Overall
Symbol
Price
% Chg
No Data